羚锐制药:核24H1净利增长30%,扎实的品牌及营销工作或将助力业绩创新高
Lingrui Pharma(600285) 信达证券·2024-08-13 08:10
| --- | --- | |----------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...